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ABSTRACT
Methods: The present case–control study included a total of 638 human subjects (318 T2DM subjects and 320 healthy controls). Various 
anthropometric, biochemical, and genetic parameters were studies in all the subjects. Genotyping of TCF7L2 gene was carried out using allele-specific 
polymerase chain reaction method.
Results: The results of this study indicate significantly higher values of body mass index, waist circumference, waist-to-hip ratio, and body fat (%) in 
T2DM subjects than controls (p≤0.001). Dyslipidemia represented by higher levels of triglycerides and reduced values of high-density lipoprotein was 
more predominant in diabetic subjects compared to healthy subjects. The frequency of risk genotype (TT) frequency was significantly higher in T2DM 
subjects (16.4%) compared to controls (11.6%). The “T” allele was more dominant in diabetic subjects than controls. Logistic regression analysis of 
the data revealed a significant association of TT genotype with 2-fold (odds ratio with 95% of confidence interval; 2.09 [1.29–3.42] p=0.003) and CT 
genotype with 1.7-fold (1.73 [1.23–2.44] p=0.002) increased risk of developing T2DM.
Conclusions: The present study demonstrated a significant association of rs7903146 (C/T) variant in TCF7L2 with the augmented risk of T2DM in 
North Indian population.
Keywords: Single-nucleotide polymorphism, Transcription factor 7-like 2, Type 2 diabetes mellitus, Insulin resistance, Asian Indians.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is one of the most challenging 
problems of the 20th century. T2DM is characterized by hyperglycemia, 
impaired insulin secretion or insulin resistance, is the most common 
type of diabetes accounting 90–95% of total diabetic cases. The 
prevalence of T2DM is rising rapidly across the globe posing significant 
socioeconomic burden in the form of lost productivity and stress on 
health-care system, both in developed and developing countries [1]. 
At present, T2DM affects 285 million people all over the world and is 
predicted to rise to 642 million by 2040 globally [2]. At present, India 
has 85 million individuals suffering from T2DM; however, this number 
is expected to rise to 109 million by 2035 [3]. India has become diabetic 
capital of the world. About 80% of the diabetic population lives in 
low- and middle-income countries. T2DM is a very complex metabolic 
disease in which both genetic and environmental factors play an 
important role in their pathophysiology [4]. The recent advancement 
in technology had made it possible to identify new genetic loci as 
well as genes associated with the risk of the development of T2DM. 
These genetic determinants can be used to better understanding of 
the pathogenesis of a disease, help in the development of policies to 
counter the economic burden, and provide a new way for improved and 
preventive therapeutic measures.
Transcription factor 7-like 2 (TCF7L2) gene is located on the long arm 
of chromosome 10q25.3 and involved in Wnt signaling pathway which 
plays a pivotal role in cell development and growth regulation [5]. The 
previous studies established TCF7L2 gene as possible determinants of 
type 2 diabetes [6,7]. Although several single-nucleotide polymorphisms 
(SNPs) in TCF7L2 gene have been replicated in different population 
and ethnicities, few studies have been done in Indian population. 
Furthermore, genetic association of TCF7L2 gene has not yet been 
explored in North Indian population. Hence, the present study was 
planned to investigate the association of rs7903146 (C/T) variant in 
TCF7L2 with the risk of T2DM in North Indian population.
METHODS
Study population
The present study included 638 participants (318 T2DM patients and 
320 healthy controls) recruited from North Indian population. The 
diagnosis of T2DM was done using criteria established by the American 
Diabetes Association as follows: A medical record indicating either a 
fasting glucose levels >7.0 mmol/l or >126 mg/dl after a minimum 
12-h fast or 2-h post-glucose level (oral glucose tolerance test or 
2-h) >11.1 mmol/l or >200 mg/dl on more than one occasion with 
symptoms of diabetes. All procedures performed in studies involving 
human participants were in accordance with the ethical standards 
of the institutional and/or national research committee and with the 
1964 Helsinki Declaration and its later amendments or comparable 
ethical standards. This study was ethically approved by the Institutional 
Ethics Committees of Post Graduate Institute of Medical Education 
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Research Article
We aimed to explore the possible association of rs7903146 (C/T) variant in TCF7L2 with the risk of T2DM in the North Indian population.
Objectives: The variants of transcription factor 7-like 2 (TCF7L2) gene have been shown to be associated with type 2 diabetes mellitus (T2DM) and its 
related complications.
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and Research, Chandigarh and Panjab University, Chandigarh, India. 
A model consent form adhering to Indian, and International guidelines 
regarding the use of human subjects were used along with detailed 
questionnaire of details regarding demographic and socioeconomic 
characteristics. The participant’s self-reported age, sex, educational 
status, physical activity, dietary habits, family history of the disease and 
individual’s smoking and alcohol use, etc., were recorded.
Anthropometric measurements
Standard anthropometric measurements were performed including 
stature, weight, and waist and hip circumferences. Body mass index 
(BMI) was calculated according to Quetelet equation (BMI = weight in 
kilograms/height in meters squared). Waist-to-hip ratio (WHR) was 
calculated as ratio of abdomen to hip circumferences. Blood pressure 
(BP) was measured using Omron’s BP machine in a sitting position, 
from the left arm resting on the table, with legs uncrossed and feet flat.
The abdominal obesity was measured according to the new cutoffs 
proposed for South Asian Indians as mentioned in our previous 
study [8], i.e., WHR >0.89 for men and >0.81 for women. BMI <23 kg/m2 
has been proposed for low risk, 23–27.5 kg/m2 for increased risk, and 
≥27.5 kg/m2 for high risk for developing weight-related diseases in 
Asian populations.
Clinical parameters
Venous blood samples were extracted from each subject after 12 h 
of fasting. A serum sample was analyzed for fasting serum glucose, 
creatinine, and lipid profile (triglycerides [TG], total cholesterol 
[TC], high-density lipoprotein cholesterol [HDL-C], and low-density 
lipoprotein cholesterol [LDL-C]). Fasting and random blood glucose 
levels were measured using a portable glucometer (Abbott Optium 
Xceed, USA).
Genotyping of TCF7L2 gene
The genomic DNA was isolated from the blood using salting 
out method [9]. DNA yield was measured by absorbance at 260 nm 
and purity was checked by calculating A260/A280. Amplification of 
rs7903146 polymorphism in TCF7L2 gene was carried out using 
allele-specific polymerase chain reaction (PCR) as described in an 
earlier study [10]. Genotyping was based on differential amplification 
due to the presence of mismatches. In rs7903146 genotyping, two 
forward primers with a mismatch in their last 3’ nucleotide such a way 
that each is specific for one of the two variants of the polymorphism 
and a common reverse primer was used. The forward primers also 
contain a second mismatch at the third nucleotide from the 3′ end 
to enhance PCR specificity. The forward primers (rs7903146 C or 
rs7903146 T) specific for allele C detection: 5`GAACAATTAGAGA 
GCTAAGCACTTTTTAGAAAC 3` and forward primer for allele T detection: 
5`GAACAATTAGAGAGCTAAGCACTTTTTAGAGAT 3`, and common 
reverse primer (rs7903146 R) 5` AGATGAAATGTAGCAGTGAAGTGC 
3` were combined in two parallel PCR reactions one with primers 
rs7903146 C and rs7903146 R (PCR C) and a second with primers 
rs7903146 T and rs7903146 R (PCR T). For each sample, two PCR 
reactions were run in parallel, one with primers rs7903146 C and 
rs7903146 R (PCR C) and a second with primers rs7903146 T and 
rs7903146 R (PCR T) each containing 200 ng genomic DNA, 1X Taq 
polymerase buffer, 1.5 mM MgCl2, 10 pmol of each primer, 200 μmol/l 
dNTPs, and 1U of Taq DNA polymerase (Thermo) in a final volume of 
25 μl. DNA amplification was carried out on thermal cycler (Eppendorf 
Mastercycler Nexus Gradient) with an initial denaturation for 3 min at 
94°C, followed by 32 cycles of 1 min at 94°C, 1 min at 50°C, and 1 min 
at 72°C and final extension for 5 min at 72°C. Fig. 1 shows the amplified 
PCR products separated on 1.5% agarose gel electrophoresis.
Statistical analysis
Results were expressed as mean ± standard deviation. Chi-square 
analysis was applied to test the significance of differences in genotypic 
and allelic frequencies. Group comparisons were done using unpaired 
t-tests. p<0.05 (two tailed) was considered as statistically significant 
difference. Logistic regression analyses were performed to calculate 
odds ratio (OR) and 95% confidence intervals (CIs) for each risk 
factor. Statistical analysis was performed using IBM-SPSS for Windows, 
version 20 (SPSS, Inc., Chicago, IL).
RESULTS
Clinical and biochemical characteristics of the study subjects
Table 1 shows the clinical and biochemical characteristics of the 
study subjects. There was a no significant difference in the age of the 
diabetic and control subjects (47.13±11.7 vs. 55.3±11.3, p=0.001). 
T2DM subjects show predominant abdominal obesity reflected by 
significantly higher values of BMI (26.9±4.6 vs. 25.9±4.7, p=0.02), 
waist circumference (93.1±10.5 vs. 88.1±10.8, p=0.001), and waist to 
hip circumference (0.96±0.06 vs. 0.93±0.08, p=0.001). No significant 
difference in body fat percent was observed in T2DM subjects compared 
to controls (33.7±10.3 vs. 32.7±9.1). Although TC levels fall under the 
limit of borderline, there is no significant difference between diabetic 
and non-diabetic controls. Significantly higher values of TG and reduced 
values of HDL were reported in diabetic patients than controls. Along 
with abdominal obesity evidenced by higher BMI and WHR, 12% of 
patients were having dyslipidemia and were on lipid-lowering drugs. 
Alterations in clinical and anthropometric measurements pretend a 
risk for the development of cardiac diseases as demonstrated by higher 
TC/HDL, LDL/HDL, and TG/HDL ratio in diabetic subjects compared to 
healthy controls (Table 1).
Association of TCF7L2 gene polymorphisms with T2DM
The distribution of genotype and allelic frequencies for rs7903146 
polymorphisms of TCF7L2 gene are shown in Table 2. TCF7L2 
rs7903146 gene polymorphism analysis demonstrated that the 
frequency of risk genotype TT genotype was significantly higher in 
diabetics than in controls (16.4% vs. 11.6%). The frequency of the “T” 
allele was significantly higher in diabetic subjects (42%) compared 
with that in the healthy control subjects (33%). Furthermore, CT 
genotype frequency was more predominant in T2DM subjects 
(51.3%) than control subjects (42.2%). Logistic regression analysis of 
the data demonstrated a significant association of TT genotype with 
2-fold (OR with 95% of CI; 2.09 [1.29–3.42] p=0.003) and CT genotype 
with 1.7 fold (1.73 [1.23–2.44] p=0.002) increased risk of developing 
T2DM in this population. Under a dominant model of inheritance, T 
allele shows a significant association with type 2 diabetes (OR, 1.79 
[1.30–2.47] p=0.0004). Furthermore, no significant association was 
observed with T2DM under recessive model of inheritance (1.49 
[0.95–2.35] p=0.08).
Table 3 summarizes the comparison of clinical and biochemical 
characteristics of T2DM and control subjects according to different 
genotypes of TCF7L2 rs7903146. There were no significant differences 
in metabolic characteristics such as glucose, BMI, WC, WHR, body fat 
(%), systolic BP, diastolic BP, TC, TG, HDL, LDL, very LDL, and creatinine 
among T2DM as well as control subjects carrying CC, CT, and TT 
genotypes of rs7903146 polymorphisms in TCF7L2 gene.
Fig. 1: Agarose gel electrophoresis of transcription factor 7-like 
2 (rs7903146C/T) gene polymorphism. Lane M: 100 bp marker 
ladder; lanes (1,2) (5,6): CG genotype; lanes (3,4): GC genotype; 
lanes (7,8) (9,10): GG genotype
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Table 1: Comparison of anthropometric and clinical characteristics of the study subjects
Parameters Controls T2DM patients p-value
Mean±SD Mean±SD
BMI (kg/m2) 25.99±4.7 26.87±4.6 0.02*
Waist circumference (cm) 88.14±10.8 93.13±10.5 0.00*
Hip (cm) 95.18±10.1 96.91±10.3 0.03*
WHR 0.93±0.08 0.96±0.06 0.00*
Body fat (%) 32.69±9.1 33.71±10.3 0.18
SBP (mmHg) 115.97±8.2 130.78±15.3 0.00*
DBP (mmHg) 75.94±6.6 79.81±10.4 0.00*
Glucose (mg/dl) 92.26±11.0 146.49±53.2 0.00*
TC (mg/dl) 177.69±31.6 183.33±48.7 0.10
TG (mg/dl) 149.50±55.2 172.49±87.7 0.00*
HDL-C (mg/dl) 44.77±6.2 42.21±7.3 0.00*
LDL-C (mg/dl) 103.02±28.3 106.62±42.8 0.23
VLDL-C (mg/dl) 29.90±11.0 34.50±17.5 0.00*
Creatinine (mg/dl) 0.81±0.6 0.88±0.4 0.14
Total lipids (mg/dl) 504.87±102.7 539.15±158.8 0.00*
Castelli’s risk index I (TC/HDL) 4.05±0.9 4.47±1.4 0.00*
Castelli’s risk index II (LDL/HDL) 2.36±0.8 2.61±1.2 0.00*
Atherogenic coefficient (TG/HDL) 3.42±1.4 4.27±2.4 0.00*
Atherogenic index 0.50±0.2 0.57±0.2 0.00*
Data values are represented as mean±SD. BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, TC: Total cholesterol, HDL-C: High-density 
lipoprotein cholesterol, LDL: Low-density lipoprotein, VLDL: Very low-density lipoprotein, WHR: Waist-to-hip ratio, T2DM: Type 2 diabetes mellitus, TG: Triglyceride, 
SD: Standard deviation. *Significant difference between T2DM and control subjects. p<0.05 is considered as statistically significant value
DISCUSSION
India is currently experiencing an epidemic of DM. Both environmental 
and genetic factors contribute to the development of insulin resistance 
and type 2 diabetes [11,12]. It is evident from the previous studies 
that several genetic determinants are associated with increased risk of 
type 2 diabetes, but their conclusive role is still unclear [13]. TCF7L2 
gene is considered one of the most important candidate genes for 
T2DM, playing a key role in blood glucose homeostasis and beta-cell 
function [14]. TCFL2 encodes a basic helix-loop-helix TCF-4, which 
acts as a nuclear receptor for the Wnt/β-catenin pathway [15] and 
can preferentially bind to Wnt-responsive elements in genes induced 
by β-catenin [16]. It is well known that the β-catenin/TCF-4 complex 
participates in various biological events. Particularly, the complex has 
been found to have an important role in pancreas islet cell proliferation 
and differentiation and thus contributes to T2DM initiation and 
progression.
Following the initial report by Grant et al. [17] showing that TCF7L2 
variants were strongly associated with T2DM risk, several other studies 
consistently replicated this association in different ethnicities [6]. The 
present case–control study established the association of 2-fold increased 
diabetes risk with TT homozygous, while CT heterozygous carried 1.7-
fold increase in T2DM risk when compared with CC homozygous of 
rs7903146 polymorphisms in the TCF7L2 gene. Bodhini et al. observed 
a significant association between the T allele of rs7903146(C/T) 
SNPs and T2DM in South Indians [18]. Chandak et al. also observed a 
strong association of rs7903146 polymorphism with T2DM (OR=1.46) 
[19]. A previous study revealed a positive significant association 
between TT genotype of rs7903146 (C/T) variant of TCF7L2 gene 
and diabetes-related complications in Indian population [20]. Several 
studies conducted in other parts of the world demonstrated significant 
relationship between TCF7L2 gene and T2DM in British [21], the US 
[22], Finnish [23], Amish [24], Scandinavian [25], Polish [25], French 
[26], Dutch Breda [27], European Whites, migrant Asian Indian, Afro-
Caribbean [28], Northern Swedish [29], and Japanese populations [30]. 
A large meta-analysis study confirmed the association of TCF7L2 gene 
with T2DM in different ethnicities [31]. Our results are similar with the 
results from the overall meta-analysis of the rs7903146 polymorphism 
wherein heterozygous genotype CT carried over a 1.4-fold increased 
risk for T2DM, while TT homozygous carried near a 2.0-fold increase 
in T2DM risk when compared with CC homozygous. Another meta-
analysis study examining 66 studies also confirmed the association 
of the rs7903146 SNPs with T2DM in 66 studies (OR = 1.41, 95% CI 
1.37–1.46 for the T allele) [32]. A similar meta-analysis study in Chinese 
population also reflected the role of rs7903146(C/T) SNP towards 
Table 2: Test of association depicting TCF7L2 (rs7903146) gene polymorphism as a risk for T2DM in North Indian population
Genotypes Human participants Test of association
Controls T2DM patients Odds ratio (95% of CI) Pearson Chi-square
CC 148 (46.2%) 103 (32.4%) Reference
CT 135 (42.2%) 163 (51.3%) 1.73 (1.23–2.44) p=0.002 10.18
TT 37 (11.6%) 52 (16.4%) 2.09 (1.29–3.42) p=0.003 9.01
Total 320 318
Allele C 0.67 0.58
Allele T 0.33 0.42
Dominant model (CC vs. CT+TT)
CC 148 103
CT+TT 172 215 1.79 (1.30–2.47) p=0.0004 12.84
Recessive model (CC+CT vs. TT)
CC+CT 283 266
TT 37 52 1.49 (0.95–2.35) p=0.08 3.05
Data are presented as number (%) unless otherwise stated. T2DM: Type 2 diabetes mellitus, CI: Confidence interval, TCF7L2: Transcription factor 7-like 2. p<0.05 is 
considered as statistically significant value
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increased susceptibility to T2DM (OR = 1.54, 95% CI 1.37- 1.74 for the 
T allele) [33]. A study by Lou et al. indicated that four SNPs of TCF7L2 
(rs7903146, rs12255372, rs11196205, and rs290487) were associated 
with T2DM risk in East Asian [34]. Eight TCF7L2 polymorphisms in 155 
studies with 121,174 subjects (53,385 cases and 67,789 controls) were 
addressed in their meta-analysis. Significant association was established 
between T2DM risk and rs7903146 and many other polymorphisms in 
TCF7L2 gene under an additive inheritance model.
The present study did not find any link between SNP rs7903146 and 
abnormalities in cardiometabolic traits including BMI, WHR, and 
dyslipidemia. Similar results were observed in the previous studies 
conducted in India. Chandak et al. observed no significant association 
with BMI or WHR in T2DM patients or control subjects [19]. Also, no 
significant difference in respect to metabolic parameters between 
different genotypes of rs7903146(C/T was observed [36]. Contrary, 
many studies show the association of TCF7L2 gene polymorphism 
with many metabolic traits [6,17,35-38]. Cauchi et al. found that the T 
allele of rs7903146 predicts hyperglycemia in French population [26]. 
Saxena et al. found that individuals homozygous for the rs7903146 risk 
allele had a significant reduction in insulinogenic index and insulin 
disposition index [25]. Damcott et al. found significant association with 
insulin sensitivity index, acute insulin response to glucose in non-Amish 
Caucasian subjects [24]. Our results showed that the rs7903146 T allele 
of the TCF7L2 gene was positively correlated with an enhanced risk of 
T2DM in codominant and dominant models of inheritance.
CONCLUSIONS
The present study confirms the association of rs7903146 (C/T) 
polymorphism in TCF7L2 gene with risk of T2DM in North Indian 
population. However, no significant influence of this polymorphism was 
observed with cardiometabolic traits.
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